Gliomagenesis, Epileptogenesis, and Remodeling of Neural Circuits: Relevance for Novel Treatment Strategies in Low- and High-Grade Gliomas
- PMID: 39201639
- PMCID: PMC11354416
- DOI: 10.3390/ijms25168953
Gliomagenesis, Epileptogenesis, and Remodeling of Neural Circuits: Relevance for Novel Treatment Strategies in Low- and High-Grade Gliomas
Abstract
Gliomas present a complex challenge in neuro-oncology, often accompanied by the debilitating complication of epilepsy. Understanding the biological interaction and common pathways between gliomagenesis and epileptogenesis is crucial for improving the current understanding of tumorigenesis and also for developing effective management strategies. Shared genetic and molecular mechanisms, such as IDH mutations and dysregulated glutamate signaling, contribute to both tumor progression and seizure development. Targeting these pathways, such as through direct inhibition of mutant IDH enzymes or modulation of glutamate receptors, holds promise for improving patient outcomes. Additionally, advancements in surgical techniques, like supratotal resection guided by connectomics, offer opportunities for maximally safe tumor resection and enhanced seizure control. Advanced imaging modalities further aid in identifying epileptogenic foci and tailoring treatment approaches based on the tumor's metabolic characteristics. This review aims to explore the complex interplay between gliomagenesis, epileptogenesis, and neural circuit remodeling, offering insights into shared molecular pathways and innovative treatment strategies to improve outcomes for patients with gliomas and associated epilepsy.
Keywords: epilepsy; epileptogenesis; glioma; gliomagenesis; neurosurgery.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients.Cancer Sci. 2012 Mar;103(3):587-92. doi: 10.1111/j.1349-7006.2011.02175.x. Epub 2012 Jan 13. Cancer Sci. 2012. PMID: 22136423 Free PMC article.
-
Molecular Classification of Gliomas is Associated with Seizure Control: A Retrospective Analysis.Neuromolecular Med. 2021 Jun;23(2):315-326. doi: 10.1007/s12017-020-08624-0. Epub 2020 Nov 18. Neuromolecular Med. 2021. PMID: 33206320 Free PMC article.
-
Isocitrate dehydrogenase 1-mutated human gliomas depend on lactate and glutamate to alleviate metabolic stress.FASEB J. 2019 Jan;33(1):557-571. doi: 10.1096/fj.201800907RR. Epub 2018 Jul 12. FASEB J. 2019. PMID: 30001166
-
IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma.Neuro Oncol. 2013 Sep;15(9):1114-26. doi: 10.1093/neuonc/not087. Epub 2013 Jul 21. Neuro Oncol. 2013. PMID: 23877318 Free PMC article. Review.
-
Advances in genetic and epigenetic analyses of gliomas: a neuropathological perspective.J Neurooncol. 2014 Sep;119(3):481-90. doi: 10.1007/s11060-014-1499-x. Epub 2014 Jun 25. J Neurooncol. 2014. PMID: 24962200 Review.
Cited by
-
Gene mutations linked to drug-resistant epilepsy in astrocytoma.Front Neurol. 2025 Mar 4;16:1523468. doi: 10.3389/fneur.2025.1523468. eCollection 2025. Front Neurol. 2025. PMID: 40103938 Free PMC article.
-
Bioinformatic Characterization of the Functional and Structural Effect of Single Nucleotide Mutations in Patients with High-Grade Glioma.Biomedicines. 2024 Oct 9;12(10):2287. doi: 10.3390/biomedicines12102287. Biomedicines. 2024. PMID: 39457600 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical